HYBRID EVENT: You can participate in person at Dubai or Virtually from your home or work.
Conference Banner

2nd International Conference on Cancer Research & Immuno-Oncology

April 3,4,5 2026 | Atlantis the Royal, Palm Jumeirah - Crescent Road - Dubai

“Redefining Cancer Care Through Precision Medicine & Immunotherapy”

Phone: +1 (347) 820 9966

Whatsapp: +44 7861 668671

Email: info@researchersfusion.com

2nd International Conference on Cancer Research & Immuno-Oncology
Keynote Presentation (In-Person)
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya | University of California San Francisco, United States
2nd International Conference on Cancer Research & Immuno-Oncology

Background: Current screening methods, have limitations in the diagnosis and prognosis of prostate cancer. This study examined whether mRNA-genomic biomarkers can improve screening and monitoring of prostate cancer. Methods: We identified a panel of 25 prostate cancer-related genes through rigorous… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Keynote Presentation (In-Person)
Title : Theory and perspective: How big data and AI accelerate the discovery of a universal cancer principle from the noncoding RNA regime
Anyou Wang | DIFIBER LLC, United States
2nd International Conference on Cancer Research & Immuno-Oncology

Numerous cancer-related mechanisms are reported daily, yet a universal theory for eradicating all cancers remains elusive. Fortunately, recent advances in big data and AI have identified noncoding RNAs as central players in all cancers, challenging the conventional protein-centric view. However,… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title :  Superficial radiation ulcer of the skin: Comparison of the innovative photodynamic therapy (used in the first documented Canadian case) with other alternatives
Patricia Tai | UpToDate, Canada
2nd International Conference on Cancer Research & Immuno-Oncology

Introduction: Photodynamic therapy (PDT) promotes wound healing while its clinical use is not investigated in human for radiation-induced skin ulcers. Methods and Materials: We documented the first Canadian in-human case and searched the PubMed literature using “PDT" AND "radiation" AND… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson | University of Toronto, Canada
2nd International Conference on Cancer Research & Immuno-Oncology

Biosensor technology represents an attractive strategy for the detection and monitoring of biomarkers for disease states within the context of precision medicine. This approach offers the possibility for biomarker assay via incorporation into an automated robotic system to process and… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Human Serum Albumin in the Presence of Small Platinum Nanoparticles
Sandrine Lacombe | University of Paris-Saclay, France
2nd International Conference on Cancer Research & Immuno-Oncology

Noble metal materials, especially platinum nanoparticles (Pt NPs), have immense potential in nanomedicineas therapeutic agents on account of their high electron density and their high surface area. Intravenous injec-tion is proposed as the best mode to deliver the product to… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Personalized and precision oncology via integrating genomics, pathology-related modeling, and IT-assisted approaches to prevent, treat, and cure cancer and its complications
Sergey Suchkov | N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
2nd International Conference on Cancer Research & Immuno-Oncology

Individualizing patient treatment is a core objective of the medical field. Meanwhile, the inherent variability of cancer illustrating the molecular differences between tumors, securing the linkages of those differences to an effective drug and resulting in immense patient benefits, lends… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar | UT MD Anderson Cancer Center, United States
2nd International Conference on Cancer Research & Immuno-Oncology

Gastric adenocarcinoma (GAC) remains one of the leading causes of cancer-related mortality worldwide, largely due to its late-stage diagnosis, limited treatment options, and poorly understood molecular drivers. Recent studies have implicated epigenetic dysregulation in GAC pathogenesis, yet the functional role… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : A new tension-sensitive signaling pathway involving polymerization of actin prevents chromatin bridge breakage in cytokinesis
Eleni Petsalaki | University of Crete, Greece
2nd International Conference on Cancer Research & Immuno-Oncology

Chromatin bridges are strands of incompletely segregated DNA connecting the anaphase poles or daughter nuclei. Chromatin bridges can arise from incompletely replicated DNA, defective resolution of DNA catenates or dicentric chromosomes which are formed by chromosome fusions. If unresolved, chromatin… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Coping strategies and business profitability in self-employed cancer survivors of varied types
Miri Cohen | University of Haifa
2nd International Conference on Cancer Research & Immuno-Oncology

Aim Although awareness of the effect of cancer on self-employed individuals is growing, few studies have explored processes of coping in relation to the changes in cancer survivors’ business operations. We examined (a) the perceived effects of cancer on business… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : The role of emotion regulation, self-compassion, and perceived lifestyle discrepancy in maintaining a healthy lifestyle among breast cancer survivors
Svetlana Baziliansky | University of Haifa, Israel
2nd International Conference on Cancer Research & Immuno-Oncology

Aims: An unhealthy lifestyle elevates the risk of comorbidities, cancer recurrence, and diminished quality of life among breast cancer survivors. Yet, the influence of psychosocial factors on sustaining healthy lifestyle behaviors (physical activity and healthy diet) in this population remains underexplored.… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Decentralising and decolonising urology palliative care psychosocial services: A model for Nelson Mandela Academic Hospital, urology clinic, Eastern Cape
Awam Mavimbela | Nelson Mandela Academic Hospital, South Africa
2nd International Conference on Cancer Research & Immuno-Oncology

Background: Patients with advanced urological conditions in the Eastern Cape face multiple barriers to quality palliative psychosocial care: centralised specialist services, limited integration of culturally relevant practices, transport and cost burdens, and mistrust rooted in historical marginalisation. Decentralising services and… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Keynote Presentation (In-Person)
Title : Genomic analyses of circulating cell free DNA in follicular lymphoma: Diagnostic prognostic and therapeutic implications
Can Kucuk | Dokuz Eylul University, Turkey
2nd International Conference on Cancer Research & Immuno-Oncology

In this talk, the potential of cfDNA genotyping on diagnosis and prognostication of follicular lymphoma (FL) will be presented.  As a frequent non-Hodgkin lymphoma type, FL is generally indolent with a variable clinic presentation including asymptomatic as well as symptomatic… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Keynote Presentation (In-Person)
Title : Effect of heterosteroids derived from sapogenin in PI3K/AKT/mTOR and apoptosis pathways in breast cancer cells
Nadia Leney Olazo Marquez | Benemérita Universidad Autónoma de Puebla, Mexico
2nd International Conference on Cancer Research & Immuno-Oncology

Introduction: Cancer is one of the leading causes of mortality; breast cancer is the most frequent type worldwide and in Mexico. Therefore, treatment options such as heterosteroids continue to be investigated. To establish their effect on breast cancer, in silico… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan | The Affiliated Cancer Hospital of Nanjing Medical University, China
2nd International Conference on Cancer Research & Immuno-Oncology

Background Drug resistance, including Adriamycin-based therapeutic resistance, remains a challenge in breast cancer (BC) treatment. Studies have revealed that macrophages could play a pivotal role in mediating the chemoresistance of cancer cells. Accumulating evidence suggests that tRNA-Derived small RNAs (tDRs) are… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Application of a machine learning-based tumor risk prediction system to assist in precise diagnosis of prostate cancer and biopsy decision-making
Zhou Yu | Shenzhen People's Hospital, China
2nd International Conference on Cancer Research & Immuno-Oncology

Objective: To develop a prediction model for prostate biopsy based on machine learning algorithms and create a tumor risk prediction system, aiming to achieve precise diagnosis of prostate cancer and assist in biopsy decision-making. Methods: Clinical data were retrospectively collected from 2007… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Spatial multi-omics inference of diabetes-triggered pancreatic cancer growth: The key role of cholesterol-induced neutrophil extracellular
Guanqun Li | The First Affiliated Hospital of Harbin Medical University, China
2nd International Conference on Cancer Research & Immuno-Oncology

Objective: Pancreatic ductal adenocarcinoma (PDAC) patients with diabetes mellitus (DM) are associated with poor clinical outcome, while the mechanism remains unclear. Metabolic reprogramming of cancer cells and immune compartments determines the anti-tumor immune response in PDAC. DM-derived metabolic reprogramming can alter… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : BMI-dependent surgical approach selection and risk of postoperative complications in elderly patients undergoing pancreaticoduodenectomy: Insights into the gut microbiota link
Zhihan Miao | The First Affiliated Hospital of Harbin Medical University, China
2nd International Conference on Cancer Research & Immuno-Oncology

Objective: This study aimed to identify the risk factors associated with postoperative complications in elderly patients (≥65 years) undergoing pancreaticoduodenectomy, determine the key moderating factor influencing the choice of surgical approach (open vs. minimally invasive), and preliminarily explore the potential… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Alendronate functionalized bone-targeting pomolic acid liposomes restore bone homeostasis for osteoporosis treatment
Liu Ying | Shanghai University, China
2nd International Conference on Cancer Research & Immuno-Oncology

Osteoporosis, characterized by an imbalance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation, severely affects elderly health. Currently, there are no effective treatments, highlighting the need for new therapies. Salvia miltiorrhiza Bunge, a traditional Chinese medicine, has long been used… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Online)
Title : Evaluation of mutational values in cancerous point mutation and innovation of values- effective drugs for cancer treatment
Ratan Kumar Sarkar | Independent Researcher, India
2nd International Conference on Cancer Research & Immuno-Oncology

The molecular weights of amino acids are time values where integer and decimal part have separate identity but interrelated. Derived from the factor 14.0267 e.g. 119.1197(Thr) – 105.0930(Ser) = 14.0267 = 131.1736(Leu) – 117.1469(Val), the formula T(time) = 0.0019*M(integer) is… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (Online)
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina | All India Institute of Medical Sciences, India
2nd International Conference on Cancer Research & Immuno-Oncology

[18F]FDG PET/CT has become an integral component in the evaluation of Multiple Myeloma (MM), offering significant advantages in disease detection, staging, treatment response assessment, and prognostication. The Italian Myeloma criteria for PET Use (IMPeTUs) provide a standardized framework for interpreting… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (Online)
Title : Efficient anticancer properties of ashwagandha extracted phytochemicals for lower protein expression on U-251 and clove extracts on LN-229 GBM cell lines
Prabha Muddobalaiah | Ramaiah Institute of Technology, India
2nd International Conference on Cancer Research & Immuno-Oncology

Glioblastoma Multiforme G IV primary malignant Brain tumor medications such as Radiation, Surgery, Gene therapy, Chemotherapy and Ayurveda which are not very much successful with clinical studies. However, the trials are being made towards the various cancers’ successful treatment with… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (Online)
Title : One-step salivary gelatinase activity assay: Accelerating non-invasive oral malignancy diagnosis
Deovrat N Begde | Dr. Ambedkar College, India
2nd International Conference on Cancer Research & Immuno-Oncology

Matrix metalloproteinases (MMPs), notably the soluble gelatinases MMP-2 and MMP-9, are central to extracellular matrix remodeling and are frequently dysregulated during tumor invasion and metastatic progression, making them attractive biomarkers for early detection and prognosis of oral malignancies; however, commonly… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Online)
Title : Mental health needs and psychosocial burden among patients attending the oncology clinic at Nelson Mandela Academic Hospital, Mthatha: A mixed-methods cross-sectional study
Kanyiso Zweni | Walter Sisulu University, South Africa
2nd International Conference on Cancer Research & Immuno-Oncology

Nelson Mandela Academic Hospital (NMAH) is a tertiary teaching hospital in Mthatha that has recently expanded oncology services to better serve patients across the Eastern Cape. Regional analyses highlight limited oncology capacity, a high burden of advanced-stage cancers, and recognised… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Online)
Title : Beauty of herbal medicine in the global fight for cancer
Najjemba Eseza Precious | Mengo Senior School, Uganda
2nd International Conference on Cancer Research & Immuno-Oncology

Introduction: Cancer remains one of the leading causes of mortality worldwide, with conventional treatments such as chemotherapy, radiation, and surgery often causing severe side effects. Natural medicine has gained attention as a potential complementary approach to cancer care. CANEZA, a… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Online)
Title :  Stakeholder engagement process for multinational lung cancer control programme for Malawi
Tumaini Malenga | Facilitators of Community Transformation (FACT Malawi), Malawi
2nd International Conference on Cancer Research & Immuno-Oncology

Introduction: Lung cancer remains a critical public health concern globally. With a variation of risk factors, it remains the leading cause of cancer-related death and has a considerably high burden in sub-Saharan Africa . There is a deficiency in data… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Keynote Presentation (In-Person)
Title : Effectiveness of homoeopathic medicine for brochogenic carcinoma: A case report with pre & post HRCT report
Amir Ashraf | Dr. Amir’s Family Homoeopathy Clinic, India
2nd International Conference on Cancer Research & Immuno-Oncology

Homoeopathy is an alternative system of medicine discovered by German physician Samuel Hahnemann in 1796. It has been used by several people for various health conditions globally for more than last 200 years. In India, homoeopathy is considered as a… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Keynote Presentation (In-Person)
Title : Autophagy as an immunomodulatory signalosome in toll-like receptors/Wnt-Frizzled mediated inflammatory “gastrohepatic disease-web” in hepatocellular/colorectal/cholangio- carcinomas: Translational research and public health impact in American cohorts of Texas, Nebraska and New York states in USA
Saumya Pandey | Indira IVF Hospital, India
2nd International Conference on Cancer Research & Immuno-Oncology

Objective: Dissecting the cellular/molecular/genetic regulatory biochemical signaling networks: Autophagy/Toll-like Receptors/Wnt-Frizzled in inflammatory “gastrohepatic disease-web” primarily hepatocellular/colorectal/cholangiocarcinomas is essential for diminishing the disproportionate share of morbidities and mortalities in susceptible “at-risk” American cohorts of Texas, Nebraska and New York states in… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (Online)
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood | Jamia Hamdard University, India
2nd International Conference on Cancer Research & Immuno-Oncology

Osteosarcoma (OS) is a malignant bone cancer often linked to bone degradation caused by excessive osteoclast activity. Recent advancements in nanotechnology have greatly advanced the development of tumor-specific drug delivery nanocarriers (NCs), including smart and functionalized NCs, aimed at improving… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (Online)
Title : Impact of diclofenac on expression of POTE family genes POTEE and POTEB in epithelial ovarian cancer cell lines
Keerthi Teja | All India Institute of Medical Sciences, India
2nd International Conference on Cancer Research & Immuno-Oncology

Ovarian Cancer (OC) is the 3rd most common gynecological cancer worldwide with high morbidity and mortality rate and Epithelial Ovarian Cancer (EOC) is the most common subtype (90%). Despite advances in treatment, late diagnosis and inadequate therapeutic options continue to… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title :  Protective role of silymarin against methotrexate induced nephropathy in rabbit
Sohag Talukder | Sylhet Agricultural University, Bangladesh
2nd International Conference on Cancer Research & Immuno-Oncology

The experiment aimed to investigate the protective effects of Silymarin (SMN) against methotrexate (MTX) induced nephropathy in rabbits. In a randomized control trial, a total of 20 rabbits were allocated into 4 different groups each containing 5 rabbits. The first… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Personalized radiation oncology in periampullary carcinoma: Integrating Circulating Tumor DNA (ctDNA) and Stereotactic Body Radiation Therapy (SBRT) for precision monitoring and treatment optimization
Farhin Humayra | Shaheed Suhrawardy Medical College and Hospital, Bangladesh
2nd International Conference on Cancer Research & Immuno-Oncology

New molecular diagnostic tools, such as circulating tumor DNA (ctDNA), and an emphasis on pinpoint accuracy are changing radiation oncology. By integrating stereotactic body radiation therapy (SBRT) with ctDNA tracking from liquid biopsies, this study investigates a new way to… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Targeting the gut-heart axis: Exploring the role of the gut microbiome in cancer therapy- induced cardiotoxicity and prospects for microbiome-based prevention
Nishat Tamanna Rupa | Uttara Adhunik Medical College and Hospital, Bangladesh
2nd International Conference on Cancer Research & Immuno-Oncology

Cardiotoxicity makes it harder to maximize cancer survival rates; radiation and chemotherapy do more than just harm cells directly; they also worsen irreversible heart damage. By addressing a significant knowledge vacuum about the precise role of the gut microbiome in… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : A systematic review of medical art therapy for cancer patients
Manijeh Firoozi | University of Tehran, Iran
2nd International Conference on Cancer Research & Immuno-Oncology

Background: Art therapy has gained recognition as a valuable complementary treatment for cancer patients, helping to alleviate emotional and psychological stress. This systematic review aims to explore the efficacy of various types of medical art therapy and identify characteristics that contribute… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Advanced dosimetric modeling of ¹²⁵I balloon brachytherapy for GBM treatment: A comparative study using MCNP
Amir Kazemi | Shiraz University of Medical Science, Iran
2nd International Conference on Cancer Research & Immuno-Oncology

Background: Iodine-125 balloon brachytherapy is an innovative technique for delivering localized low-dose-rate radiation after the surgical removal of malignant brain tumors. The spherical shape of post-resection cavities makes the balloon applicator an effective choice for achieving conformal and isotropic dose… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : The impact of social marketing based intervention on educating esophageal cancer preventive behaviors
Davoud Shojaeizadeh | Tehran University of Medical Sciences, Iran
2nd International Conference on Cancer Research & Immuno-Oncology

Esophageal cancer is one of the most widespread disease in Golestan Province , Iran. To identify risk factors a lot of research has been done. Because health workers have successful experiences of health education. The purpose of this study is… » Read More

2nd International Conference on Cancer Research & Immuno-Oncology
Presentation (In-Person)
Title : Stem cell transplantation for cancer therapy-induced infertility
Alieh Bashghareh | Shahroud University of Medical Sciences, Iran
2nd International Conference on Cancer Research & Immuno-Oncology

Introduction: Spermatogonial stem cell transplantation (SSCT) offers a promising strategy to restore fertility in childhood cancer survivors. Chemotherapy agents like busulfan and cadmium cause oxidative damage, which impairs spermatogenesis. Metformin, known for its antioxidant properties, may help protect against this damage… » Read More

Watsapp